People Related To Glioblastoma Multiforme Research

Samy Y. Lamouille, Ph.D.

Assistant Professor, Basic Science Education, Virginia Tech Carilion School of Medicine
Research Assistant Professor, Biological Sciences, College of Science, Virginia Tech
Research Assistant Professor, Virginia Tech Carilion Research Institute

Stefanie Robel, Ph.D.

Assistant Professor, Virginia Tech Carilion Research Institute
Assistant Professor, School of Neuroscience, College of Science, Virginia Tech
Assistant Professor, Basic Science Education, Virginia Tech Carilion School of Medicine

Zhi Sheng, Ph.D.

Assistant Professor, Virginia Tech Carilion Research Institute
Assistant Professor of Internal Medicine, Virginia Tech Carilion School of Medicine

Harald Sontheimer, Ph.D.

Executive Director and Professor, School of Neuroscience, College of Science, Virginia Tech
Professor, Virginia Tech Carilion Research Institute
Director, VTCRI Center for Glial Biology in Health, Disease, and Cancer
I. D. Wilson Chair in the College of Science, Virginia Tech
Commonwealth Eminent Scholar in Cancer Research

Events Related To Glioblastoma Multiforme

The Role of Autophagy in Glioblastoma

Sept. 7, 2011, noon at Virginia Tech Carilion Research Institute

Zhi Sheng, PhD


Postdoctoral Fellow, Howard Hughes Laboratory, Program in Gene Function and Expression, University of Massachusetts Medical School, Worcester, Massachusetts

Special Seminars

Stories Related To Glioblastoma Multiforme

Scientists solve century-old neuroscience mystery; answers may lead to epilepsy treatment

Nov. 6, 2018

Scientists at the Virginia Tech Carilion Research Institute have solved a 125-year-old mystery of the brain, and, in the process, uncovered a potential treatment for acquired epilepsy. The research team ...

VTCRI research team identifies a potential strategy in fight against brain cancer

Sept. 11, 2018

Scientists with the Virginia Tech Carilion Research Institute say a gene involved in the body’s sleep cycle is a potential target for therapies to help patients with a deadly form ...

Scientists identify new target for developing precision treatment in malignant brain tumors

Jan. 25, 2018

A Virginia Tech Carilion Research Institute team has identified a new therapeutic target to treat glioblastoma, the most devastating and common form of brain cancer.

Virginia Tech Carilion Research Institute teams converge on strategies to defeat McCain’s form of brain cancer

July 26, 2017

Research teams at the Virginia Tech Carilion Research Institute from three colleges — Engineering, Science, and Veterinary Medicine — are developing new approaches to treat glioblastoma, the aggressive form of ...

Researchers find way to make resistant brain cancer cells sensitive to treatment

Nov. 16, 2015

Scientists from the Virginia Tech Carilion Research Institute and clinicians from Carilion Clinic have discovered how to sensitize drug-resistant human glioblastoma cells to chemotherapy.

Institute scientists visualize potential brain cancer treatments in real time

April 9, 2015

Virginia Tech Carilion Research Institute scientists have developed new imaging techniques to watch dangerous brain tumor cells respond to treatment in real time.

Going viral: Targeting brain cancer cells with a wound-healing drug

Dec. 12, 2014

At the Virginia Tech Carilion Research Institute, three scientists are planning to create a virus capable of destroying brain cancer. It sounds like the stuff of science fiction, but it ...

Publications Related To Glioblastoma Multiforme

Pridham KJ, Varghese RT, Sheng Z. (2017). The Role of Class IA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunits in Glioblastoma. Frontiers in Oncology 7(312).

Pridham KJ, Le L, Guo S, Varghese RT, Algino S, Liang Y, Fajardin R, Rodgers CM, Simonds GR, Kelly DF, Sheng Z. (2017). PIK3CB/p110β is a Selective Survival Factor for Glioblastoma. Neuro-Oncology.

Varghese RT, Lian Y, Guan T, Franck CT, Kelly DF, Sheng Z. (2016). Survival kinase genes present prognostic significance in glioblastoma. Oncotarget.

Murphy SF, Varghese RT, Lamouille S, Guo S, Pridham KJ, Kanabur P, Osimani AM, Sharma S, Jourdan J, Rodgers CM, Simonds GR, Gourdie RG, Sheng Z. (2016). Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide. Cancer Research 76(1): 139-49.

Li T, Murphy S, Kiselev B, Bakshi KS, Zhang J, Eltahir A, Zhang Y, Chen Y, Zhu J, Davis RM, Madsen LA, Morris JR, Karolyi DR, LaConte SM, Sheng Z, Dorn HC. (2015). A New Interleukin-13 Amino-Coated Gadolinium Metallofullerene Nanoparticle for Targeted MRI Detection of Glioblastoma Tumor Cells. Journal of the American Chemical Society 137(24): 7881-8.

Pohlmann ES, Patel K, Guo S, Dukes MJ, Sheng Z, Kelly DF. (2015). Real-time visualization of nanoparticles interacting with glioblastoma stem cells. Nano Letters 15(4): 2329-35.